FDA.reportPublic FDA data

risdiplam 5 MG Oral Tablet [Evrysdi]

RxCUI
2705369
RxNorm name
risdiplam 5 MG Oral Tablet [Evrysdi]
Display name
risdiplam 5 MG Oral Tablet [Evrysdi]
Full name
risdiplam 5 MG Oral Tablet [Evrysdi]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EVRYSDIRISDIPLAMGenentech, Inc.eceb9a99-7191-4be5-87c3-0102707cf98e2026-02-19Adverse reactionsExact identifier
rxcui: 2705369

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
eceb9a99-7191-4be5-87c3-0102707cf98eEvrysdi 5 MG Oral Tablet [PSN] · risdiplam 5 MG Oral Tablet [Evrysdi] [SBD] · Evrysdi 5 MG Oral Tablet [SY]326These highlights do not include all the information needed to use EVRYSDI safely and effectively. See full prescribing information for EVRYSDI. EVRYSDI ® (risdiplam) for oral solution EVRYSDI ® (risdiplam) tablets, for oral use Initial U.S. Approval: 202020260219